BioCentury | Nov 13, 2020
Translation in Brief
Roche and Immune-Onc mAb data; plus Capricor’s exosome-based COVID-19 vaccine induces cellular immunity, and more
...to develop COVD-19. The team, led by Public Health England...
...College London Immune-Onc Therapeutics Inc. Capricor Therapeutics Inc. Johns Hopkins University Public Health England Oxford...
...College London Immune-Onc Therapeutics Inc. Capricor Therapeutics Inc. Johns Hopkins University Public Health England Oxford...